Fund Holdings — Altium Capital Management LLC

Total Portfolio Value:
$335.67M
Total Bought:
$133.83M
Total Sold:
$72.15M
Net Transaction:
+$61.68M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Vera Therapeutics, Inc.CL A(VERA)714,000684,000-30,000$25.83M$30.23M9.01%+$4.40M
Adma Biologics Inc1,510,0001,360,000-150,000$16.88M$27.19M8.10%+$10.30M
Sarepta Therapeutics, Inc.(SRPT)81,900170,000+88,100$12.94M$21.23M6.33%+$8.29M
Edwards Lifesciences Corp0222,000+222,000$0$14.65M4.36%+$14.65M
Xenon Pharmaceuticals Inc.(XENE)360,600360,6000$14.06M$14.20M4.23%+$137.0K
Zevra Therapeutics, Inc.(ZVRA)1,162,4161,700,000+537,584$5.70M$11.80M3.51%+$6.10M
Intra-Cellular Therapies Inc193,000154,000-39,000$13.22M$11.27M3.36%-$1.95M
Soleno Therapeutics Inc212,909212,9090$8.69M$10.75M3.20%+$2.06M
Glaukos Corporation(GKOS)077,000+77,000$0$10.03M2.99%+$10.03M
Insmed Incorporated(INSM)190,000130,000-60,000$12.73M$9.49M2.83%-$3.24M
Merit Medical Systems, Inc.(MMSI)085,000+85,000$0$8.40M2.50%+$8.40M
Rezolute, Inc.(RZLT)1,700,0001,700,0000$7.31M$8.24M2.46%+$935.0K
Vaxcyte, Inc.(PCVX)072,000+72,000$0$8.23M2.45%+$8.23M
Avadel Pharmaceuticals Plc610,000610,0000$8.58M$8.00M2.38%-$576.5K
Viking Therapeutics, Inc.(VKTX)122,000126,000+4,000$6.47M$7.98M2.38%+$1.51M
Catalyst Pharmaceuticals Inc500,000385,000-115,000$7.75M$7.65M2.28%-$91.2K
Contineum Therapeutics, Inc.CL A(CTNM)429,340369,126-60,214$7.56M$7.07M2.10%-$495.6K
Arrowhead Pharmaceuticals, Inc.(ARWR)0355,000+355,000$0$6.88M2.05%+$6.88M
Savara Inc.(SVRA)1,575,0001,575,0000$6.35M$6.68M1.99%+$330.8K
iRhythm Holdings, Inc.(IRTC)086,000+86,000$0$6.38M1.90%+$6.38M
Evolus, Inc.(EOLS)0355,000+355,000$0$5.75M1.71%+$5.75M
Establishment Labs Holdings Inc.(ESTA)0131,000+131,000$0$5.67M1.69%+$5.67M
RxSight, Inc.(RXST)0112,000+112,000$0$5.54M1.65%+$5.54M
Axsome Therapeutics, Inc.(AXSM)50,00058,000+8,000$4.03M$5.21M1.55%+$1.19M
Skye Bioscience, Inc.(SKYE)1,350,0931,315,146-34,947$10.81M$5.14M1.53%-$5.67M
Xtant Medical Holdings, Inc.(XTNT)7,415,4137,415,4130$4.67M$5.01M1.49%+$341.1K
Larimar Therapeutics, Inc.(LRMR)693,000693,0000$5.02M$4.54M1.35%-$485.1K
Capricor Therapeutics, Inc.(CAPR)0285,000+285,000$0$4.33M1.29%+$4.33M
Pulmonx Corporation(LUNG)0500,000+500,000$0$4.14M1.23%+$4.14M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)0195,000+195,000$0$4.02M1.20%+$4.02M
Keros Therapeutics, Inc.(KROS)069,000+69,000$0$4.01M1.19%+$4.01M
The RealReal, Inc.(REAL)1,250,2381,270,000+19,762$3.99M$3.99M1.19%-$459
Perspective Therapeutics, Inc.(CATX)191,450290,000+98,550$1.91M$3.87M1.15%+$1.96M
Biohaven Ltd.(BHVN)075,000+75,000$0$3.75M1.12%+$3.75M
ORIC Pharmaceuticals, Inc.(ORIC)405,000355,000-50,000$2.86M$3.64M1.08%+$775.4K
Structure Therapeutics IncADS070,000+70,000$0$3.07M0.92%+$3.07M
Outlook Therapeutics, Inc.(OTLK)501,785541,549+39,764$3.70M$2.89M0.86%-$811.3K
Vericel Corporation(VCEL)068,000+68,000$0$2.87M0.86%+$2.87M
Cybin D/B/A Helus Pharma(HELP)0317,000+317,000$0$2.82M0.84%+$2.82M
Terns Pharmaceuticals Inc0330,000+330,000$0$2.75M0.82%+$2.75M
Ocugen, Inc.(OCGN)02,350,000+2,350,000$0$2.33M0.69%+$2.33M
MoonLake ImmunotherapeuticsCL A(MLTX)115,00040,000-75,000$5.06M$2.02M0.60%-$3.04M
Bicycle Therapeutics PlcADS085,000+85,000$0$1.92M0.57%+$1.92M
Veru Inc.(VERU)2,276,6922,028,534-248,158$1.92M$1.56M0.46%-$355.4K
AtriCure, Inc.(ATRC)054,000+54,000$0$1.51M0.45%+$1.51M
CytomX Therapeutics, Inc.(CTMX)0915,000+915,000$0$1.08M0.32%+$1.08M
enVVeno Medical Corporation(NVNO)0238,920+238,920$0$802.8K0.24%+$802.8K
Tempest Therapeutics, Inc.(TPST)0545,000+545,000$0$763.0K0.23%+$763.0K
Promis Neurosciences Inc0581,395+581,395$0$726.7K0.22%+$726.7K
Milestone Pharmaceuticals Inc.(MIST)1,012,368440,000-572,368$1.34M$668.8K0.20%-$667.5K
Karyopharm Therapeutics Inc.(KPTI)740,000740,0000$642.0K$614.2K0.18%-$27.8K
Unicycive Therapeutics Inc01,473,000+1,473,000$0$600.8K0.18%+$600.8K
Fat Brands IncW EXP 07 16 202200,000200,0000$569.0K$499.0K0.15%-$70.0K
Cellectar Biosciences, Inc.(CLRB)0215,000+215,000$0$460.1K0.14%+$460.1K
SRX Global Inc.(SRXH)0133,117+133,117$0$278.2K0.08%+$278.2K
Expion Energy, Inc.(XPON)02,057,494+2,057,494$0$106.4K0.03%+$106.4K
Nexgel IncW EXP 12 01 202225,000225,0000$98.3K$91.5K0.03%-$6.9K
Scorpius Holdings Inc088,291+88,291$0$63.6K0.02%+$63.6K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)731,561731,5610$44.4K$51.2K0.02%+$6.8K
Onfolio Holdings, Inc.W EXP 01 02 202(ONFO)200,000200,0000$49.8K$34.0K0.01%-$15.8K
Wearable Devices LtdW EXP 09 14 2021,411,6001,411,6000$70.0K$28.1K0.01%-$41.9K
Mobix Labs, Inc.W EXP 99 99 999(MOBX)150,000150,0000$26.8K$22.3K0.01%-$4.5K
Cingulate Inc.W EXP 12 10 202(CING)270,000270,0000$2.9K$18.7K0.01%+$15.8K
Nektar Therapeutics(NKTR)011,419+11,419$0$14.8K0.00%+$14.8K
Nexalin Technology IncW EXP 99 99 999105,000105,0000$35.7K$8.4K0.00%-$27.3K
BNB Standard CorporationW EXP 02 11 202(BNC)250,000250,0000$3.8K$6.3K0.00%+$2.5K
VSee Health, Inc.W EXP 99 99 999(VSEE)150,000150,0000$32.5K$6.0K0.00%-$26.5K
Bitcoin Depot IncW EXP 06 30 20250,00050,0000$2.4K$2.5K0.00%+$130
Nexera Technologies LtdW EXP 99 99 999(NEXR)68,68168,6810$2.2K$2.4K0.00%+$247
Nls Pharmaceutics LtdW EXP 02 02 202200,000200,0000$6.9K$2.3K0.00%-$4.6K
Cycurion, Inc.W EXP 99 99 999(CYCU)100,000100,0000$3.7K$2.2K0.00%-$1.5K
CDT Equity Inc.W EXP 09 22 202(CDT)100,000100,0000$1.6K$1.6K0.00%+$45
Coliseum Acquisition CorpW EXP 08 22 20228,33328,3330$1.4K$1.4K0.00%$0
Surrozen, Inc.W EXP 08 01 203(SRZN)82,23382,2330$1.4K$1.0K0.00%-$321
Tc Biopharm Holdings PlcW EXP 02 10 20218,82318,8230$235$3430.00%+$108
Achieve Life Sciences Inc216,3100-216,310$1.02M$0—-$1.02M
Alimera Sciences Inc2,150,0000-2,150,000$11.95M$0—-$11.95M
Allurion Technologies Inc969,8400-969,840$967.5K$0—-$967.5K
Applied Dna Sciences Inc86,1520-86,152$35.2K$0—-$35.2K
Aprea Therapeutics, Inc.(APRE)137,1970-137,197$558.4K$0—-$558.4K
argenx SEADR(ARGX)23,0000-23,000$9.89M$0—-$9.89M
Ascendis Pharma A/SADR(ASND)50,0000-50,000$6.82M$0—-$6.82M
BioVie Inc.CL A(BIVI)1,982,3410-1,982,341$793.9K$0—-$793.9K
Boundless Bio, Inc.(BOLD)83,1490-83,149$321.8K$0—-$321.8K
Cemtrex Inc339,9610-339,961$74.8K$0—-$74.8K
Context Therapeutics Inc.(CNTX)360,0010-360,001$721.8K$0—-$721.8K
Cybin D/B/A Helus Pharma(HELP)13,953,4880-13,953,488$3.78M$0—-$3.78M
Evoke Pharma Inc692,4400-692,440$366.3K$0—-$366.3K
Intelligent Bio Solutions In83,9060-83,906$161.1K$0—-$161.1K
Lexicon Pharmaceuticals, Inc.(LXRX)121,9860-121,986$204.9K$0—-$204.9K
Perfect Moment Ltd. Common Stock(PMNT)62,8350-62,835$135.1K$0—-$135.1K
Quoin Pharmaceuticals LtdADS103,1270-103,127$59.8K$0—-$59.8K
Selina Hospitality PlcW EXP 10 27 202101,4390-101,439$1.1K$0—-$1.1K
Spruce Biosciences Inc811,1670-811,167$419.9K$0—-$419.9K
Ultragenyx Pharmaceutical Inc.(RARE)70,0000-70,000$2.88M$0—-$2.88M
Page 1 of 1
Altium Capital Management LLC — 13F Holdings — Q3 2024 | TickerTrail